Defunct Company
Total Trials
13
As Lead Sponsor
0
As Collaborator
Total Enrollment
1,655
NCT00777348
To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol
Phase: Phase 2
Role: Collaborator
Start: Nov 30, 2007
Completion: Oct 31, 2008
NCT00884689
A 6 Months NIS to Evaluate the Use of Rescue Medication and Quality of Life in Adult Asthmatic Subjects Treated With Symbicort® SMART®
Phase: N/A
Start: Apr 30, 2009
Completion: Jun 30, 2010
NCT01190852
Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal Sprays
Phase: Phase 1
Start: Aug 31, 2010
Completion: Oct 31, 2010
NCT01194622
Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal Sprays
NCT01256086
Relative Potency of Formoterol Novolizer® 12 µg Compared to Formoterol Aerolizer® 12 µg
Start: Dec 31, 2010
Completion: Jul 31, 2011
NCT01276704
Prevention Strategy for Pre-Menopausal Women at High Risk for Development of Breast Cancer
Start: Jan 31, 2011
Completion: Jul 31, 2017
NCT03652051
A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)
Start: Sep 10, 2018
Completion: Oct 19, 2022
NCT04602975
A Study to Investigate the Safety and Immunogenicity of the SF2a-TT15 Synthetic Carbohydrate-based Conjugate Vaccine Against Shigella Flexneri 2a
Start: Oct 6, 2020
Completion: Nov 15, 2023
NCT05887310
In Vitro Modeling of Drug-resistant Psychiatric Disorders Using Induced Pluripotent Cells
Start: Aug 5, 2022
Completion: Aug 5, 2024
NCT06321172
Muscle and Bone Changes After 6 Months of FES Cycling
Start: Sep 9, 2022
Completion: Apr 29, 2024
NCT06292897
Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression
Start: Mar 20, 2023
Completion: Jan 15, 2027
NCT05941234
Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma
Start: Feb 29, 2024
Completion: Dec 30, 2026
NCT06519045
PK of Codeine and Metabolites in Human Fingerprint Sweat, Oral Fluid, Blood and Urine
Start: Jun 11, 2024
Completion: Sep 30, 2024